A new guideline has been made available from the American Academy of Neurology on the difficult issue of whether to stop antithrombotic medication during surgery or other medical procedures. The ...

The periprocedural use of aspirin or unfractionated heparin during endovascular treatment of acute ischemic stroke was associated with an increased risk of symptomatic intracranial hemorrhage without ...

The incidence of subdural hematomas is increasing, especially in people 75 and older, with the trend occurring at the same time as antithrombotics are being used more frequently, a Danish study shows.

Dr. Neil Hayward, CEO and founder of eXlthera, is here to discuss his company, which is developing Factor XI inhibitor antithrombotics that are attacking blood clots from a new angle and are giving ...

Antithrombotic therapy is “not justified” in mildly symptomatic COVID-19 patients who are recovering at home and have no other indication for taking the drugs, investigators for the ACTIV-4b trial ...

Antithrombotic therapy during percutaneous coronary intervention for ST-segment elevation myocardial infarction has evolved substantially over the past 15 years. With the results of the ATOLL trial, ...

Antithrombotics, which include blood thinners or anticoagulants, help prevent clot formation in certain diseases. Doctors did not know which antithrombotic drug, what dose, and at what point during ...

Abciximab blocks the sticking of platelets together and protects the arteries by reducing the formation of thrombus or blood clot. Acenocoumarol is a blood thinner agent prescribed to treat or prevent ...

A recent news release by the National Institutes of Health (NIH) announces the start of two Phase 3 clinical trials to explore blood thinners as treatments for COVID-19. These trials, known as ACTIV-4 ...